Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Actinium Pharmaceuticals Inc (ATNM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Actinium Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.060 +0.100    +1.44%
24/04 - Closed. Currency in USD ( Disclaimer )
After Hours
7.060
0.000
0.000%
20:00:00 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 153,407
  • Bid/Ask: 6.880 / 7.390
  • Day's Range: 6.881 - 7.320
Actinium Pharmaceuticals 7.060 +0.100 +1.44%

ATNM Recent Sentiments

 
This page contains information on users’ sentiments for the Actinium Pharmaceuticals Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 18, 2024 Ignacio Carrasco...   7.061 -0.01%
Apr 05, 2024 FRITZ Jean Marie   9.420 -25.05%
Mar 21, 2024 Gennaro Orlando   9.122 Apr 12, 2024 @ 9.000 -1.34%
Mar 11, 2024 David Gonzalez   7.040 Apr 05, 2024 @ 9.530 +35.37%
Feb 14, 2024 fede alca   5.300 Mar 08, 2024 @ 7.650 +44.34%
Feb 13, 2024 ALEJANDRO BLAZQUEZ   5.460 Mar 08, 2024 @ 7.650 +40.11%
Sep 26, 2023 Santiago Urgell...   6.370 Nov 30, 2023 @ 4.190 -34.22%
May 01, 2023 Gennaro Orlando   9.010 Nov 30, 2023 @ 4.190 -53.50%
Apr 03, 2023 Сергей Ляхов   9.137 May 09, 2023 @ 8.650 -5.33%
Mar 02, 2023 kurt vanmeerhaeghe   10.250 Mar 24, 2023 @ 9.340 -8.88%
Feb 23, 2023 David Gonzalez   9.180 Mar 17, 2023 @ 9.280 +1.09%
Feb 22, 2023 ALEJANDRO BLAZQUEZ   9.030 Mar 17, 2023 @ 9.280 +2.77%
Feb 22, 2023 Bader Alnaqeeb   10.320 Mar 17, 2023 @ 9.280 -10.08%
Feb 21, 2023 Massimiliano Cecchini   12.750 Mar 17, 2023 @ 9.280 -27.22%
Feb 16, 2023 Rayme Marrero   14.185 Mar 10, 2023 @ 8.510 -40.01%
Feb 10, 2023 Gennaro Orlando   12.830 Mar 03, 2023 @ 10.130 -21.04%
Feb 01, 2023 Kristina Göransson   11.710 Feb 06, 2023 @ 12.070 +3.07%
Jan 24, 2023 Kristina Göransson   11.640 Jan 30, 2023 @ 11.280 -3.09%
Jan 06, 2023 ALEJANDRO BLAZQUEZ   10.325 Jan 27, 2023 @ 11.560 +11.96%
Dec 19, 2022 raymond colas   10.610 Jan 13, 2023 @ 10.150 -4.34%
Nov 22, 2022 Hao Wang   10.258 Dec 16, 2022 @ 11.090 +8.11%
Nov 17, 2022 Сергей Ляхов   11.770 Dec 09, 2022 @ 10.770 -8.50%
Nov 08, 2022 Gennaro Orlando   11.730 Dec 02, 2022 @ 11.270 -3.92%
Nov 01, 2022 Ignacio Carrasco...   13.430 Nov 28, 2022 @ 11.000 -18.09%
Oct 31, 2022 Gemma Vicente Muñoz   12.020 Nov 28, 2022 @ 11.000 -8.49%
Oct 31, 2022 mura demirtaş   11.809 Nov 28, 2022 @ 11.000 +6.85%
Oct 31, 2022 Aaron Rochon   11.110 Nov 07, 2022 @ 11.228 +1.06%
Oct 26, 2022 Jouko Kella   8.760 Nov 18, 2022 @ 11.940 +36.30%
Oct 10, 2022 Gennaro Orlando   7.975 Nov 04, 2022 @ 10.895 +36.61%
Sep 13, 2022 kurt vanmeerhaeghe   8.320 Oct 07, 2022 @ 7.700 -7.45%
Sep 12, 2022 ramazan sürer   8.420 Oct 07, 2022 @ 7.700 -8.55%
Aug 25, 2022 Gennaro Orlando   6.380 Sep 16, 2022 @ 7.980 +25.08%
May 19, 2022 Gennaro Orlando   6.145 Jun 10, 2022 @ 5.080 -17.33%
Apr 21, 2022 Jordi Arcalis   6.867 May 13, 2022 @ 5.750 -16.27%
Apr 19, 2022 Gennaro Orlando   7.030 May 13, 2022 @ 5.750 -18.21%
Apr 12, 2022 David Alal   6.920 May 06, 2022 @ 5.720 -17.34%
Apr 12, 2022 Maor Cohen   6.925 May 06, 2022 @ 5.720 -17.40%
Apr 12, 2022 Ralf Weinert   6.367 May 06, 2022 @ 5.720 -10.16%
Mar 07, 2022 Bryan Sirota   5.000 Mar 14, 2022 @ 4.645 -7.10%
Jan 24, 2022 Paolo Viscione   5.430 Feb 18, 2022 @ 5.080 -6.45%
Jan 10, 2022 Gennaro Orlando   6.040 Feb 04, 2022 @ 5.230 -13.41%
Dec 03, 2021 ابو احمد   6.375 Dec 24, 2021 @ 6.570 +3.06%
Nov 18, 2021 Maria Diczhazi   7.710 Dec 10, 2021 @ 6.850 -11.15%
Nov 17, 2021 Paul Nevosh   7.850 Dec 10, 2021 @ 6.850 -12.74%
Nov 10, 2021 Gennaro Orlando   8.000 Dec 03, 2021 @ 6.350 -20.63%
Oct 13, 2021 frank cuennet   8.435 Nov 05, 2021 @ 8.360 -0.89%
Sep 30, 2021 IGNACIO BARRAU   8.770 Oct 22, 2021 @ 8.250 -5.93%
Sep 24, 2021 Jim Delaune   10.100 Oct 15, 2021 @ 8.040 -20.40%
Sep 24, 2021 franco calegari   9.700 Oct 15, 2021 @ 8.040 -17.11%
Sep 22, 2021 Raul Muñoz   8.190 Sep 27, 2021 @ 9.830 +20.02%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ATNM Comments

Write your thoughts about Actinium Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
kurt vanmeerhaeghe
kurt vanmeerhaeghe Feb 18, 2023 8:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
get in before it's too late
kurt vanmeerhaeghe
kurt vanmeerhaeghe Nov 05, 2022 3:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
after the recent decline, time to buy more
Donna Saldi
Donna Saldi Apr 21, 2021 12:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy this investment today.....get in and hold!
Donna Saldi
Donna Saldi Mar 25, 2021 12:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy and holdA gem of a stock....gl........this is going to be a blockbuster....no joke
Donna Saldi
Donna Saldi Mar 01, 2021 7:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
100% engraftment,gals and guys!lovin this.....bullish!
Donna Saldi
Donna Saldi Feb 16, 2021 7:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy and hold.....no brainer!
Ehsan Haidari
Ehsan Haidari Jan 05, 2021 2:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is this a good or bad stock to buy?
Pete Pearson
Pyxis2025 Jan 05, 2021 2:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Long term good, short bad.
Duane Goodson
Duane Goodson Jan 04, 2021 11:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RDGL 0.125 By 1/16/2021 FDA will provide a final decision to grant or deny their request for breakthrough designation.
Matthew Whittaker
Matthew Whittaker Dec 30, 2020 6:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pacific Edge (PEB) let's go! 🥳 🚀
Jorge Fabrizio
Jorge Fabrizio Oct 16, 2020 10:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
12.50!!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email